Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-28 Option Award |
2025-01-30 4:02 pm |
N/A 2035-01-28 |
Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer |
221,000 | $0 | 221,000 (Direct) |
View |
2025-01-28 Option Award |
2025-01-30 4:01 pm |
N/A 2035-01-28 |
Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO |
500,000 | $0 | 500,000 (Direct) |
View |
2024-10-31 Option Award |
2024-11-01 4:31 pm |
N/A 2034-10-31 |
Carisma Therapeutics Inc. | CARM | Cheng Sohanya Roshan Director |
38,700 | $0 | 38,700 (Direct) |
View |
2024-07-01 Option Award |
2024-07-01 7:19 pm |
N/A 2034-07-01 |
Carisma Therapeutics Inc. | CARM | Thorell Marella Director |
38,700 | $0 | 38,700 (Direct) |
View |
2024-07-01 Option Award |
2024-07-01 7:17 pm |
N/A 2034-07-01 |
Carisma Therapeutics Inc. | CARM | Scadden David Director |
38,700 | $0 | 38,700 (Direct) |
View |
2024-06-26 Option Award |
2024-06-27 4:56 pm |
N/A 2034-06-26 |
Carisma Therapeutics Inc. | CARM | ZWEIFACH SANFORD S Director |
19,350 | $0 | 19,350 (Direct) |
View |
2024-06-26 Option Award |
2024-06-27 4:54 pm |
N/A 2034-06-26 |
Carisma Therapeutics Inc. | CARM | Morrison Briggs Director |
19,350 | $0 | 19,350 (Direct) |
View |
2024-06-26 Option Award |
2024-06-27 4:53 pm |
N/A 2034-06-26 |
Carisma Therapeutics Inc. | CARM | Hohneker John Director |
19,350 | $0 | 19,350 (Direct) |
View |
2024-06-26 Option Award |
2024-06-27 4:51 pm |
N/A 2034-06-26 |
Carisma Therapeutics Inc. | CARM | Torok Michael Director |
19,350 | $0 | 19,350 (Direct) |
View |
2024-06-17 Option Award |
2024-06-18 7:08 pm |
N/A 2034-06-17 |
Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer |
85,000 | $0 | 85,000 (Direct) |
View |
2024-06-17 Option Award |
2024-06-18 7:06 pm |
N/A 2034-06-17 |
Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer |
85,000 | $0 | 85,000 (Direct) |
View |
2024-06-17 Option Award |
2024-06-18 7:05 pm |
N/A 2034-06-17 |
Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO |
125,000 | $0 | 125,000 (Direct) |
View |
2024-04-01 Option Award |
2024-04-01 6:59 pm |
N/A 2034-04-01 |
Carisma Therapeutics Inc. | CARM | Hohneker John Director |
38,700 | $0 | 38,700 (Direct) |
View |
2024-01-31 Option Award |
2024-02-02 4:53 pm |
N/A 2034-01-31 |
Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer |
170,500 | $0 | 170,500 (Direct) |
View |
2024-01-31 Option Award |
2024-02-02 4:53 pm |
N/A 2034-01-31 |
Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer |
170,500 | $0 | 170,500 (Direct) |
View |
2024-01-31 Option Award |
2024-02-02 4:52 pm |
N/A 2034-01-31 |
Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO |
438,000 | $0 | 438,000 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:20 pm |
N/A 2033-06-06 |
Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO |
600,000 | $0 | 600,000 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:19 pm |
N/A 2033-06-06 |
Carisma Therapeutics Inc. | CARM | ZWEIFACH SANFORD S Director |
38,700 | $0 | 38,700 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:18 pm |
N/A 2033-06-06 |
Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer |
238,000 | $0 | 238,000 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:16 pm |
N/A 2033-06-06 |
Carisma Therapeutics Inc. | CARM | Torok Michael Director |
38,700 | $0 | 38,700 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:15 pm |
N/A 2033-06-06 |
Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer |
238,000 | $0 | 238,000 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:13 pm |
N/A 2033-06-06 |
Carisma Therapeutics Inc. | CARM | Ugwumba Chidozie Director |
38,700 | $0 | 38,700 (Direct) |
View |
2023-06-06 Option Award |
2023-06-08 6:11 pm |
N/A 2033-06-06 |
Carisma Therapeutics Inc. | CARM | Morrison Briggs Director |
38,700 | $0 | 38,700 (Direct) |
View |
Ownership |
2023-03-13 5:06 pm |
N/A N/A |
Carisma Therapeutics Inc. | CARM | ModernaTX Inc. 10% Owner |
0 | $0 | 5,059,338 (Direct) |
View |
2023-03-07 Option Award |
2023-03-09 9:32 pm |
N/A 2028-09-18 |
Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO |
1,041,765 | $0 | 1,041,765 (Direct) |
View |
2023-03-07 Option Award |
2023-03-09 9:31 pm |
N/A N/A |
Carisma Therapeutics Inc. | CARM | Ugwumba Chidozie Director |
2,215,877 | $0 | 2,215,877 (Indirect) |
View |
2023-03-07 Option Award |
2023-03-09 9:29 pm |
N/A N/A |
Carisma Therapeutics Inc. | CARM | Hodits Regina Director |
2,297,546 | $0 | 2,297,546 (Indirect) |
View |
2023-03-07 Option Award |
2023-03-09 9:27 pm |
N/A 2027-11-01 |
Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer |
729,369 | $0 | 729,369 (Direct) |
View |
2023-03-07 Option Award |
2023-03-09 9:26 pm |
N/A 2031-05-31 |
Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer |
331,114 | $0 | 331,114 (Direct) |
View |
2023-03-07 Option Award |
2023-03-09 9:25 pm |
N/A N/A |
Carisma Therapeutics Inc. | CARM | Torok Michael Director |
421,241 | $0 | 101,250 (Direct) |
View |
2023-03-07 Option Award |
2023-03-09 9:23 pm |
N/A 2031-11-08 |
Carisma Therapeutics Inc. | CARM | ZWEIFACH SANFORD S Director |
185,034 | $0 | 185,034 (Direct) |
View |
2023-03-07 Option Award |
2023-03-09 9:21 pm |
N/A 2030-07-23 |
Carisma Therapeutics Inc. | CARM | Morrison Briggs Director |
109,674 | $0 | 109,674 (Direct) |
View |